Reports On Company: Model Portfolio
21 Stocks for Medium/Long Term SIP: HDFC Sec Research Report | |
Company: | Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | May 7, 2021 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | Staggered buying is recommended to benefit from any future falls and have better margin of safety |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Time To Be Cautious About Some Smallcap And Midcap Stocks: HDFC Sec Report | |
Company: | Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | April 29, 2021 |
Type of Report: | Sector Report |
Recommendation: | Sell |
Upside Potential: | 90% |
Summary: | Smallcap and midcap space..is it time to be more selective? |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Covid 2.0: Investment Ideas | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | April 23, 2021 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 39% |
Summary: | Reduce NIFTY50 target to 16100 but remain cautiously optimistic |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Best Cement Stocks To Buy Now: HDFC Sec Research Report | |
Company: | HDFC Sec, Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | April 13, 2021 |
Type of Report: | Sector Report |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | long-term trends are likely to drive the cement industry over the next few years |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Top 5 Pharma Stocks To Buy Now: Edelweiss Research Report | |
Company: | Model Portfolio, Sun Pharma |
Brokerage: | Edelweiss |
Date of report: | April 12, 2021 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 22% |
Summary: | SUN PHARMA entering into an earnings upgrade cycle |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Axis Top Picks for April 2021 | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | April 1, 2021 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | New Fiscal; New Hope! |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Best 5 Specialty Ingredients Stocks To Buy Now: Research Report By Nirmal Bang | |
Company: | Advanced Enzymes Technologies, Camlin Fine Sciences, Fine Organic, Galaxy Surfactants, Model Portfolio, Rossari Biotech |
Brokerage: | Nirmal Bang |
Date of report: | April 1, 2021 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 29% |
Summary: | Indian companies are leveraging this opportunity whereby they deal with some global companies for sourcing ingredients and subsequently provide value-added solutions to clients based on their requirements |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
NIFTY Target Upgraded To 17,200 + Best 15 Stocks To Buy Now: Axis Securities Report | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | March 2, 2021 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 36% |
Summary: | Structural trends intact; Upgrade Nifty Target to 17,200 |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Top 10 Fundamentally Strong Stocks To Buy Now To Benefit From Stock Market Crash: Axis Securities | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | February 26, 2021 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | Opportunities in times of adversity! |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Top 11 Specialty Chemical Sector Stocks To Buy Or Sell: Research Report By HDFC Sec | |
Company: | Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | February 12, 2021 |
Type of Report: | Sector Report |
Recommendation: | Buy |
Upside Potential: | 23.6% |
Summary: | Bounce-back in revenue and jump in margins |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |